Experimental treatments obeldesivir and MBP134 discussed for US Ebola patient with Bundibugyo virus (utmb.edu)
0xBASE INTEL BRIEF
- UTMB expert Thomas Geisbert discusses treatments for US Bundibugyo patient
- Obeldesivir and MBP134 antibody cocktail mentioned as experimental options
- Ervebo vaccine may not be effective against Bundibugyo virus
"UTMB expert Thomas Geisbert discusses potential treatments for a US Ebola patient infected with Bundibugyo virus, including antiviral obeldesivir and antibody cocktail MBP134, as well as the Ervebo vaccine's relevance."
no comments yet.